Last reviewed · How we verify

Z7200 without oral activated charcoal

Zambon SpA · Phase 1 active Small molecule

Z7200 without oral activated charcoal is a Small molecule drug developed by Zambon SpA. It is currently in Phase 1 development. Also known as: budesonide/formoterol.

At a glance

Generic nameZ7200 without oral activated charcoal
Also known asbudesonide/formoterol
SponsorZambon SpA
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Z7200 without oral activated charcoal

What is Z7200 without oral activated charcoal?

Z7200 without oral activated charcoal is a Small molecule drug developed by Zambon SpA.

Who makes Z7200 without oral activated charcoal?

Z7200 without oral activated charcoal is developed by Zambon SpA (see full Zambon SpA pipeline at /company/zambon-spa).

Is Z7200 without oral activated charcoal also known as anything else?

Z7200 without oral activated charcoal is also known as budesonide/formoterol.

What development phase is Z7200 without oral activated charcoal in?

Z7200 without oral activated charcoal is in Phase 1.

Related